On Demand webinar: The new BTS/SIGN/NICE guideline for asthma: What it means for you
AstraZeneca has provided sponsorship towards this independent Programme and has had no involvement in its creation or organisation
This webinar featured short presentations and discussions from our amazing and vastly experienced panel: Carol Stonham, Kevin Gruffydd-Jones, Deborah Leese, Helena Cummings and Darush Attar-Zadeh, chaired by our Executive Vice-Chair Ren Lawlor.
After many years of navigating through competing asthma guidelines the long awaited release of the single UK asthma guideline from BTS, SIGN and NICE will be released at the end of November. The advice regarding how asthma is diagnosed and managed will change considerably based on newer evidence and increasing availability of diagnostic tests and multiple treatments.
What will that mean to how you diagnose and treat asthma? This webinar considers the crucial changes to asthma care and what primary care will need to consider to be able to implement the changes in practice.
Resources:
IPCRG Reliever Reliance Test (English)
Slides:
Are you ready for the new asthma guideline?
New BTS/NICE/SIGN Guideline on Asthma: diagnosis, monitoring and chronic asthma management 2024Today (27th November) the National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) publish their long-awaited single guideline on asthma diagnosis, monitoring and management.
You may also be interested in...
This is a high-level summary of what the new BTS/NICE/SIGN Asthma: diagnosis monitoring and chronic asthma management guideline means for you as a primary healthcare professional and what steps you need to take to implement it effectively.
This webinar is part of the PCRS Maintenance and Reliever Therapy (MART) in asthma campaign which seeks to support understanding and implementation of MART in asthma, and, with that, best practice asthma care.